Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| IDEXX LABORATORIES INC /DEIDXX · Entity 3057 | Senior Vice President | February 23, 2022 | February 25, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
IDEXX LABORATORIES INC /DE
Report date February 23, 2022 · Filed February 25, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,329.478 |
Ending reported balance
After 2022-02-23 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-02-23 · Exercise / conversion · Acquired 706 · Balance 18,436.478 Row 2 · 2022-02-23 · Exercise / conversion · Acquired 1,893 · Balance 20,329.478 |
| Incentive Stock Option (right-to-buy)SEC Table II · derivative / convertible security · Conversion / exercise price $141.60 · Expires 2027-02-13 | Direct | 0 |
Reported balance
After 2022-02-23 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-02-23 · Exercise / conversion · Disposed 706 · Balance 0 F3: Not applicable. F1: Grant of option to buy 706 shares of Issuer common stock that vested in one installment on February 14, 2022. |
| Non-Qualified Stock Option (right-to-buy)SEC Table II · derivative / convertible security · Conversion / exercise price $288.78 · Expires 2030-02-13 | Direct | 3,784 |
Reported balance
After 2022-02-23 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-02-23 · Exercise / conversion · Disposed 1,893 · Balance 3,784 F3: Not applicable. F2: Grant of option to buy 7,570 shares of Issuer common stock that vest in four annual installments beginning February 14, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of option to buy 706 shares of Issuer common stock that vested in one installment on February 14, 2022.
F2: Grant of option to buy 7,570 shares of Issuer common stock that vest in four annual installments beginning February 14, 2021.
F3: Not applicable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 31, 2020 Filed Sep 2, 2020 21:00 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionNon-Qualified Stock Option (right-to-buy) · Derivative | 1,316 | Not disclosed Strike: $79.54 | Not disclosed |
DisclosureSEC source: 0001567619-20-016342 · doc1.xml · derivative · entry 6 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,316 shares Expires 2025-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: Not applicable. F4 · derivative.exercise_date: Grant of option to buy 9,677 shares of IDEXX Laboratories, Inc. common stock that vested in five annual installments beginning February 14, 2016 without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split. Read SEC document |
| August 31, 2020 Filed Sep 2, 2020 21:00 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | SaleCommon Stock | 1,285 | $389.08 | $499,965.10 |
DisclosureSEC source: 0001567619-20-016342 · doc1.xml · nonDerivative · entry 5 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,906 F3 · price: Represents the weighted average price of the shares sold ranging from a low of $389.02 to a high of $389.16 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 31, 2020 Filed Sep 2, 2020 21:00 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | SaleCommon Stock | 2,788 | $388.79 | $1,083,951.54 |
DisclosureSEC source: 0001567619-20-016342 · doc1.xml · nonDerivative · entry 4 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,191 F2 · price: Represents the weighted average price of the shares sold ranging from a low of $388.01 to a high of $389.01 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 31, 2020 Filed Sep 2, 2020 21:00 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | SaleCommon Stock | 3,243 | $387.33 | $1,256,103.41 |
DisclosureSEC source: 0001567619-20-016342 · doc1.xml · nonDerivative · entry 3 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,979 F1 · price: Represents the weighted average price of the shares sold ranging from a low of $387.00 to a high of $387.96 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 31, 2020 Filed Sep 2, 2020 21:00 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 6,000 | $67.85 | $407,100.00 |
DisclosureSEC source: 0001567619-20-016342 · doc1.xml · nonDerivative · entry 2 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,222 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2020 Filed Sep 2, 2020 21:00 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 1,316 | $79.54 | $104,674.64 |
DisclosureSEC source: 0001567619-20-016342 · doc1.xml · nonDerivative · entry 1 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,222 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 28, 2020 Filed Aug 31, 2020 21:18 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionNon-Qualified Stock Option (right-to-buy) · Derivative | 9,682 | Not disclosed Strike: $79.54 | Not disclosed |
DisclosureSEC source: 0001567619-20-016171 · doc1.xml · derivative · entry 7 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,316 Underlying: Common Stock · 9,682 shares Expires 2025-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Not applicable. F4 · derivative.exercise_date: Grant of option to buy 9,677 shares of IDEXX Laboratories, Inc. common stock that vested in five annual installments beginning February 14, 2016 without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split. Read SEC document |
| August 28, 2020 Filed Aug 31, 2020 21:18 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | SaleCommon Stock | 9,682 | $384.11 | $3,718,989.81 |
DisclosureSEC source: 0001567619-20-016171 · doc1.xml · nonDerivative · entry 5 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,906 F3 · price: Represents the weighted average price of the shares sold ranging from a low of $384.00 to a high of $384.50 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 28, 2020 Filed Aug 31, 2020 21:18 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 9,682 | $79.54 | $770,106.28 |
DisclosureSEC source: 0001567619-20-016171 · doc1.xml · nonDerivative · entry 4 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,588 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 21:18 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionNon-Qualified Stock Option (right-to-buy) · Derivative | 8,356 | Not disclosed Strike: $79.54 | Not disclosed |
DisclosureSEC source: 0001567619-20-016171 · doc1.xml · derivative · entry 6 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,998 Underlying: Common Stock · 8,356 shares Expires 2025-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Not applicable. F4 · derivative.exercise_date: Grant of option to buy 9,677 shares of IDEXX Laboratories, Inc. common stock that vested in five annual installments beginning February 14, 2016 without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 21:18 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | SaleCommon Stock | 400 | $389.06 | $155,624.00 |
DisclosureSEC source: 0001567619-20-016171 · doc1.xml · nonDerivative · entry 3 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,906 Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 21:18 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | SaleCommon Stock | 7,956 | $388.57 | $3,091,495.54 |
DisclosureSEC source: 0001567619-20-016171 · doc1.xml · nonDerivative · entry 2 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,306 F2 · price: Represents the weighted average price of the shares sold ranging from a low of $388.03 to a high of $388.93 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 21:18 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 8,356 | $79.54 | $664,636.24 |
DisclosureSEC source: 0001567619-20-016171 · doc1.xml · nonDerivative · entry 1 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,262 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 14 shares purchased under the Issuer's Employee Stock Purchase Plan on June 30, 2020. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 21:01 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionIncentive Stock Option (right-to-buy) · Derivative | 1,256 | Not disclosed Strike: $79.54 | Not disclosed |
DisclosureSEC source: 0001567619-20-011545 · doc1.xml · derivative · entry 9 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,256 shares Expires 2025-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · price: Not applicable. F8 · derivative.exercise_date: Grant of option to buy 628 shares of IDEXX Laboratories, Inc. common stock that became exercisable on February 14, 2020 without giving effect to Stock Split. The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 21:01 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionNon-Qualified Stock Option (right-to-buy) · Derivative | 12,814 | Not disclosed Strike: $62.00 | Not disclosed |
DisclosureSEC source: 0001567619-20-011545 · doc1.xml · derivative · entry 8 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,814 shares Expires 2024-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · price: Not applicable. F7 · derivative.exercise_date: Grant of option to buy 6,407 shares of IDEXX Laboratories, Inc. common stock that became exercisable in five annual installments beginning February 14, 2015 without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 21:01 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | SaleCommon Stock | 4,867 | $308.88 | $1,503,299.01 |
DisclosureSEC source: 0001567619-20-011545 · doc1.xml · nonDerivative · entry 7 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,892 F6 · price: Represents the weighted average price of the shares sold ranging from a low of $308.62 to a high of $309.40 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 21:01 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | SaleCommon Stock | 3,296 | $307.99 | $1,015,133.39 |
DisclosureSEC source: 0001567619-20-011545 · doc1.xml · nonDerivative · entry 6 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,759 F5 · price: Represents the weighted average price of the shares sold ranging from a low of $307.60 to a high of $308.41 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 21:01 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | SaleCommon Stock | 3,948 | $306.99 | $1,211,977.17 |
DisclosureSEC source: 0001567619-20-011545 · doc1.xml · nonDerivative · entry 5 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,005 F4 · price: Represents the weighted average price of the shares sold ranging from a low of $306.58 to a high of $307.55 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 21:01 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | SaleCommon Stock | 1,600 | $306.21 | $489,935.04 |
DisclosureSEC source: 0001567619-20-011545 · doc1.xml · nonDerivative · entry 4 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,003 F3 · price: Represents the weighted average price of the shares sold ranging from a low of $305.55 to a high of $306.47 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 21:01 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | SaleCommon Stock | 359 | $304.76 | $109,409.81 |
DisclosureSEC source: 0001567619-20-011545 · doc1.xml · nonDerivative · entry 3 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,603 F2 · price: Represents the weighted average price of the shares sold ranging from a low of $304.46 to a high of $304.98 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 21:01 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 1,256 | $79.54 | $99,902.24 |
DisclosureSEC source: 0001567619-20-011545 · doc1.xml · nonDerivative · entry 2 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,962 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 21:01 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 12,814 | $62.00 | $794,468.00 |
DisclosureSEC source: 0001567619-20-011545 · doc1.xml · nonDerivative · entry 1 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 23 shares purchased under the Issuer's Employee Stock Purchase Plan on March 31, 2020. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 02:34 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionRestricted Stock Unit · Derivative | 157 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-20-004373 · doc1.xml · derivative · entry 13 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,632 Underlying: Common Stock · 157 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020. F9 · price: Not applicable. F8 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020. F8 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 02:34 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionRestricted Stock Unit · Derivative | 168 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-20-004373 · doc1.xml · derivative · entry 12 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,789 Underlying: Common Stock · 168 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2019. F9 · price: Not applicable. F7 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2019. F7 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2019. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 02:34 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionRestricted Stock Unit · Derivative | 212 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-20-004373 · doc1.xml · derivative · entry 11 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,957 Underlying: Common Stock · 212 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2018. F9 · price: Not applicable. F6 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2018. F6 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2018. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 02:34 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionRestricted Stock Unit · Derivative | 405 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-20-004373 · doc1.xml · derivative · entry 10 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,169 Underlying: Common Stock · 405 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2017. F9 · price: Not applicable. F5 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2017. F5 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2017. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 02:34 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionRestricted Stock Unit · Derivative | 345 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-20-004373 · doc1.xml · derivative · entry 9 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,574 Underlying: Common Stock · 345 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2016. The number of RSUs have been adjusted to reflect the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015. F9 · price: Not applicable. F4 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2016. The number of RSUs have been adjusted to reflect the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015. F4 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2016. The number of RSUs have been adjusted to reflect the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 02:34 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | GrantRestricted Stock Unit · Derivative | 736 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-20-004373 · doc1.xml · derivative · entry 8 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,919 Underlying: Common Stock · 736 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021. F9 · price: Not applicable. F3 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021. F3 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 02:34 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | GrantNon-Qualified Stock Option (right-to-buy) · Derivative | 7,570 | Not disclosed Strike: $288.78 | Not disclosed |
DisclosureSEC source: 0001567619-20-004373 · doc1.xml · derivative · entry 7 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,570 Underlying: Common Stock · 7,570 shares Expires 2020-02-13 F9 · price: Not applicable. F2 · derivative.exercise_date: Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2021. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 02:34 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Tax withholdingCommon Stock | 388 | $288.78 | $112,046.64 |
DisclosureSEC source: 0001567619-20-004373 · doc1.xml · nonDerivative · entry 6 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,869 Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 02:34 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 157 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-004373 · doc1.xml · nonDerivative · entry 5 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,257 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 02:34 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 168 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-004373 · doc1.xml · nonDerivative · entry 4 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 02:34 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 212 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-004373 · doc1.xml · nonDerivative · entry 3 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,932 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 02:34 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 405 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-004373 · doc1.xml · nonDerivative · entry 2 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,720 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2020 Filed Feb 20, 2020 02:34 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 345 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-004373 · doc1.xml · nonDerivative · entry 1 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,315 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 21 shares purchased under the Issuer's Employee Stock Purchase Plan on December 31, 2019. Read SEC document |
| November 29, 2019 Filed Dec 2, 2019 22:16 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionIncentive Stock Option (right-to-buy) · Derivative | 1,612 | Not disclosed Strike: $62.00 | Not disclosed |
DisclosureSEC source: 0001567619-19-022480 · doc1.xml · derivative · entry 6 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,612 shares Expires 2024-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: Not applicable. F5 · derivative.exercise_date: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 806 shares on February 14, 2019, without giving effect to the Stock Split. The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split. Read SEC document |
| November 29, 2019 Filed Dec 2, 2019 22:16 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionNon-Qualified Stock Option (right-to-buy) · Derivative | 14,750 | Not disclosed Strike: $45.84 | Not disclosed |
DisclosureSEC source: 0001567619-19-022480 · doc1.xml · derivative · entry 5 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,750 shares Expires 2020-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: Not applicable. F4 · derivative.exercise_date: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 7,375 shares beginning February 14, 2014, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split. Read SEC document |
| November 29, 2019 Filed Dec 2, 2019 22:16 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 1,612 | $62.00 | $99,944.00 |
DisclosureSEC source: 0001567619-19-022480 · doc1.xml · nonDerivative · entry 4 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2019 Filed Dec 2, 2019 22:16 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | SaleCommon Stock | 13,306 | $251.31 | $3,343,885.62 |
DisclosureSEC source: 0001567619-19-022480 · doc1.xml · nonDerivative · entry 3 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,337 F3 · price: Represents the weighted average price of the shares sold ranging from a low of $250.81 to a high of $251.74 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 29, 2019 Filed Dec 2, 2019 22:16 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | SaleCommon Stock | 1,444 | $243.16 | $351,121.31 |
DisclosureSEC source: 0001567619-19-022480 · doc1.xml · nonDerivative · entry 2 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,643 F2 · price: Represents the weighted average price of the shares sold ranging from a low of $253.00 to a high of $253.51 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 29, 2019 Filed Dec 2, 2019 22:16 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionCommon Stock | 14,750 | $45.84 | $676,140.00 |
DisclosureSEC source: 0001567619-19-022480 · doc1.xml · nonDerivative · entry 1 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,087 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 22 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on September 30, 2019. Read SEC document |
| August 09, 2019 Filed Aug 12, 2019 22:01 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | SaleCommon Stock | 2,300 | $274.44 | $631,212.00 |
DisclosureSEC source: 0001567619-19-016395 · doc1.xml · nonDerivative · entry 1 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,315 F1 · balance_after: Includes 20 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on June 28, 2019. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 21:01 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | SaleCommon Stock | 2,600 | $250.14 | $650,363.22 |
DisclosureSEC source: 0001567619-19-012689 · doc1.xml · nonDerivative · entry 1 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,595 F1 · price: Represents the weighted average price of the shares sold ranging from a low of $249.50 to a high of $250.3250 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 06, 2019 Filed May 7, 2019 21:26 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | SaleCommon Stock | 2,015 | $250.00 | $503,750.00 |
DisclosureSEC source: 0001567619-19-010042 · doc1.xml · nonDerivative · entry 1 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,195 F1 · balance_after: Includes 32 shares of common stock acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 29, 2019. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 22:03 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | SaleCommon Stock | 1,500 | $211.77 | $317,648.25 |
DisclosureSEC source: 0001567619-19-005827 · doc1.xml · nonDerivative · entry 1 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,178 Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 23:10 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionRestricted Stock Unit · Derivative | 169 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-19-004926 · doc1.xml · derivative · entry 14 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,183 Underlying: Common Stock · 169 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: 6. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2019. F9 · price: Not applicable. F8 · derivative.exercise_date: 6. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2019. F8 · derivative.expiration_date: 6. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2019. F9 · derivative.underlying: Not applicable. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 23:10 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionRestricted Stock Unit · Derivative | 212 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-19-004926 · doc1.xml · derivative · entry 13 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,352 Underlying: Common Stock · 212 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: 6. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2018.. F9 · price: Not applicable. F7 · derivative.exercise_date: 6. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2018.. F7 · derivative.expiration_date: 6. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2018.. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 23:10 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionRestricted Stock Unit · Derivative | 405 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-19-004926 · doc1.xml · derivative · entry 12 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,564 Underlying: Common Stock · 405 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2017. F9 · price: Not applicable. F6 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2017. F6 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2017. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 23:10 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionRestricted Stock Unit · Derivative | 345 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-19-004926 · doc1.xml · derivative · entry 11 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,969 Underlying: Common Stock · 345 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2016 and has been adjusted to reflect the Stock Split. F9 · price: Not applicable. F5 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2016 and has been adjusted to reflect the Stock Split. F5 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2016 and has been adjusted to reflect the Stock Split. Read SEC document |
| February 14, 2019 Filed Feb 19, 2019 23:10 UTC | IDEXX LABORATORIES INC /DE IDXX · Entity 3057 | Exercise / conversionRestricted Stock Unit · Derivative | 282 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-19-004926 · doc1.xml · derivative · entry 10 TWIGGE GIOVANI · CIK 0001500399 · CORPORATE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,314 Underlying: Common Stock · 282 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2015. The number of RSUs have been adjusted to reflect the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015 (the "Stock Split"). F9 · price: Not applicable. F4 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2015. The number of RSUs have been adjusted to reflect the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015 (the "Stock Split"). F4 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2015. The number of RSUs have been adjusted to reflect the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015 (the "Stock Split"). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.